Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission
Conexeu Sciences announced significant progress in scaling up manufacturing, conducting regulatory testing, and advancing preclinical studies to support the planned FDA 510(k) submission of its lead wound care device candidate, Ten Minute Tissue™, in the first quarter of 2027. The company has demonstrated reproducible manufacturing processes for it…